New England Journal of Medicine · 1966 · 61 citations · 3 references
PharmacyPharmacologyPharmacotherapyCardiovascular PharmacotherapyClinical PharmacologyRenal PharmacotherapyBlood Pressure ManagementDiuretic TherapyHypertension ManagementHypertension PharmacotherapyRenal PharmacologyAntihypertensive Drug TherapyAntihypertensive PharmacologyDiuretic MechanismsPotassium-sparing Diuretic EffectsPotassium-sparing DiureticsSubjectsThiazide Diuretic Therapy
MK-870 (n-amidino-3,5 diamino-6-chloropyrazine carboxamide), is an orally effective agent that has in limited clinical use proved effective as a diuretic.1 Jones, Russo and Zacchei2 reported that this is an active potassium-sparing natriuretic agent in rats and dogs. Baer et al.3 found that small doses enhanced the natriuresis and depressed the kaliuresis produced by thiazide diuretics in dogs. The diuretic properties of the drug in "normal" subjects and its value in the treatment of hypertension alone or in conjunction with other agents has not previously been reported.Diuretic EffectsWe are here concerned with the effects of MK-870 on sodium, potassium, . . .
3
An Automatic Method for Colorimetric Analysis
Leonard T. Skeggs · American Journal of Clinical Pathology · 1957 · 708 citations